Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial
id:
antihypertensive-and-lipid-lowering-treatment-to-prevent-heart-attack-trial-278-497445
title:
Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial
text:
The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial, also known as ALLHAT, was a randomized, double-blind, active-controlled study comparing at the same time, four different classes of antihypertensive drugs with the rate of coronary heart disease (CHD) events in ‘high-risk’ people with hypertension. Participants were initially randomised to chlorthalidone (diuretic) versus doxazosin, lisinopril (ACE-inhibitor), and amlodipine. The doxazosin arm was discontinued early
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/Antihypertensive_and_Lipid_Lowering_Treatment_to_Prevent_Heart_Attack_Trial
date created:
date modified:
2024-01-24T16:38:33Z
main entity:
{"identifier":"Q294443","url":"https://www.wikidata.org/entity/Q294443"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/4/47/Grade_1_hypertension.jpg","width":3008,"height":2000}
fields total:
13
integrity:
14